JENNA BALLOU: Open Payments
NPI 1306450176 · BEAVERCREEK, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,287 in 163 payments from 19 companies in 2025. Trend: 2023 $5,284 · 2024 $3,328 · 2025 $3,287
Food & beverage: $3,287
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 12 | $443 |
| AstraZeneca Pharmaceuticals LP | 19 | $367 |
| BETA BIONICS, INC. | 10 | $303 |
| Abbott Laboratories | 14 | $286 |
| Novo Nordisk Inc | 16 | $270 |
| Lilly USA, LLC | 16 | $238 |
| Bayer Healthcare Pharmaceuticals Inc. | 13 | $192 |
| Medtronic, Inc. | 6 | $185 |
| Amgen Inc. | 11 | $164 |
| Xeris Pharmaceuticals, Inc. | 12 | $162 |
Products named: Dexcom G6 Transmitter, iLet Bionic Pancreas, FREESTYLE LIBRE 3, FARXIGA, Kerendia, MINIMED 780G, MOUNJARO, Wegovy.
Industry payments across OH — which companies pay providers there.
